1. Home
  2. ENTX vs KOPN Comparison

ENTX vs KOPN Comparison

Compare ENTX & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.88

Market Cap

142.0M

Sector

Health Care

ML Signal

HOLD

Logo Kopin Corporation

KOPN

Kopin Corporation

HOLD

Current Price

$2.57

Market Cap

424.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTX
KOPN
Founded
2010
1984
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
142.0M
424.9M
IPO Year
2018
1992

Fundamental Metrics

Financial Performance
Metric
ENTX
KOPN
Price
$1.88
$2.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$10.00
$4.25
AVG Volume (30 Days)
85.0K
3.3M
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$124,000.00
$45,602,295.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$43.33
P/E Ratio
N/A
N/A
Revenue Growth
25.25
3.02
52 Week Low
$1.50
$0.71
52 Week High
$3.22
$4.16

Technical Indicators

Market Signals
Indicator
ENTX
KOPN
Relative Strength Index (RSI) 30.33 50.42
Support Level $2.07 $2.32
Resistance Level $2.22 $2.65
Average True Range (ATR) 0.15 0.21
MACD -0.03 0.01
Stochastic Oscillator 11.49 57.26

Price Performance

Historical Comparison
ENTX
KOPN

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks: